The Effect of Physical Properties of Lipid Emulsions on Gastrointestinal Function
NCT01253005 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18
Last updated 2012-11-14
Summary
This study will investigate the effects of particle size of different triglyceride emulsions as well as the dynamics of intragastric structure formation and breakdown of the emulsions on GI function, the kinetics of the endocrine and the satiation response in healthy volunteers. 12 healthy participants will be studied on four occasions on four separate days in a double blind randomized design
Conditions
- Healthy Controls
Interventions
- BEHAVIORAL
-
Nutritional intervention
This study will investigate the effects of particle size of different triglyceride emulsions as well as the dynamics of intragastric structure formation and breakdown of the emulsions on GI function, the kinetics of the endocrine and the satiation response in healthy volunteers.
Sponsors & Collaborators
-
University of Zurich
lead OTHER
Principal Investigators
-
Michael Fried, Professor MD · University Hospital Zurich, Gastroenterology and Hepatology
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2012-11-30
- Completion
- 2012-11-30
Countries
- Switzerland
Study Locations
More Related Trials
-
Effects of Emulsification and Lipid Droplet Size on Postprandial Metabolic Responses
NCT02789683 ·Status: COMPLETED ·Phase: NA
-
Olive Oil and Soybean 1 Oil Based Intravenous Lipid Emulsions, Liver Chemistry and Clinical Outcomes
NCT03442361 ·Status: COMPLETED
-
To Study the Immunomodulating Effects and Safety Profile of ω3 and ω6 PUFA Containing Intravenous Lipid Emulsion in Patients With Acute on Chronic Liver Failure
NCT02691533 ·Status: COMPLETED ·Phase: NA
-
Characterization of Fatty Acid Composition of Triglycerides in Patients With Hypertriglyceridemia-induced Acute Pancreatitis
NCT04097990 ·Status: UNKNOWN ·Phase: NA
-
Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Associated Hepatic Injury
NCT01412359 ·Status: APPROVED_FOR_MARKETING
-
Gastric Emptying and Gallbladder Motility Study
NCT00940849 ·Status: COMPLETED ·Phase: NA
-
Effect of Bile Acids on the Secretion of Satiation Peptides in Humans
NCT01674946 ·Status: COMPLETED ·Phase: PHASE1
-
Application and Effect Evaluation of Medium Chain Fatty Acid Rich Milk Powder in Infants With Cholestatic Liver Disease
NCT05922332 ·Status: WITHDRAWN ·Phase: NA
-
Minimization of IntraLipid Versus Omegaven
NCT01247012 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Trial of Taurine Supplementation in Parenteral Nutrition 1
NCT00135044 ·Status: UNKNOWN ·Phase: NA
-
Omegaven® as Parenteral Nutrition
NCT02334293 ·Status: UNKNOWN ·Phase: NA
-
Cholestasis Prevention: Efficacy of IV Fish Oil
NCT00512629 ·Status: COMPLETED ·Phase: PHASE1
-
Intravenous Fish Oils in the Treatment of Parenteral Nutrition Liver Injury
NCT02780193 ·Status: APPROVED_FOR_MARKETING
-
SMOFLipid in Patients Who Are Intralipid Intolerant
NCT03054948 ·Status: WITHDRAWN ·Phase: PHASE4
-
Early Enteral Nutrition for Severe Acute Pancreatitis
NCT00995098 ·Status: COMPLETED ·Phase: PHASE4
-
Safely and Efficacy of ClinOleic-based Lipid Parenteral Nutrition
NCT04051840 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of Phosphatidylcholine in a Patient With Methionine Adenosyltransferase Deficiency
NCT00006061 ·Status: COMPLETED ·Phase: NA
-
Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency
NCT04227678 ·Status: RECRUITING ·Phase: NA
-
Clinical Study on the Safety of CNT-02 for TGCV and NLSD-M
NCT02830763 ·Status: TERMINATED ·Phase: NA
-
Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition
NCT00004697 ·Status: COMPLETED ·Phase: NA
-
Use of Omega 3 Oil Emulsion for Parenteral Nutrition Associated Cholestasis
NCT02148146 ·Status: NO_LONGER_AVAILABLE
-
Assess the Effect of Erythromycin on the Rate of Success in Placement of a Self-propelled Feeding Tube
NCT00999232 ·Status: COMPLETED ·Phase: PHASE4
-
Omegaven® in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury
NCT01845116 ·Status: COMPLETED ·Phase: PHASE2
-
Omegaven Protocol:Intermediate Size Patient Population
NCT03561194 ·Status: APPROVED_FOR_MARKETING
-
Low Dose Fat for the Prevention of Liver Disease in Babies With Gastrointestinal Disorders
NCT01373918 ·Status: TERMINATED ·Phase: PHASE4